INSIGHTS ON REGULATORY COMPLIANCE
-
Enabling Real-Time Data Through A PAT Integration
Explore how Raman models and autosampling tools enable real-time bioprocess control, delivering richer data and automation. Learn how PAT technologies can help close data gaps and support smarter, more efficient biomanufacturing strategies.
-
Why Perform A D-Value Study? Reference Review
Understanding how a product influences microorganisms' resistance is crucial. Read about relevant standards and references as well as recommendations for performing product D-value studies.
-
What Does The New Annex 1 Mean For The Aseptic Fill/Finish Industry?
The revised Annex 1 focuses on harmonizing regulations across the pharmaceutical manufacturing industry, prompting the pharmaceutical industry to strategize to achieve the best compliance method.
-
FAQs On The Revised EU GMP Annex 1: Volume 2
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
Mold In Cleanrooms: A Persistent Threat And The Case For Proactive Bio-Decontamination11/17/2025
Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs8/27/2024
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
How To Reduce Batch Loss In Biopharma Production12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
Developing A Comprehensive Regulatory Approach For LNP Drugs2/26/2024
The path to regulatory approval for LNPs demands carefully considered strategies. By adopting proactive and strategic approaches, developers can overcome regulatory hurdles on the path to approval.
-
Development Of Improved Chromatographic Methods7/31/2025
Explore the evolving role of GLP-1 agonists in weight management and diabetes care, and discover the urgent need for advanced chromatography methods to ensure pharmaceutical quality and safety.
REGULATORY COMPLIANCE SOLUTIONS
-
PIMS makes BioPharma manufacturing process data accessible, transferable and meaningful
-
Learn about fast, reliable ELISA readings with LED optics, robust data analysis, and automation-ready design that is validated for IVDR and FDA compliance to support efficient lab operations.
-
Become compliant with FDA 21 CFR Part 11 and EudraLex Annex 11 software validation
SoftMax® Pro 7.2 GxP Software is the latest, most secure software to achieve full FDA 21 CFR Part 11 and EudraLex Annex 11 compliance with streamlined workflows to ensure data integrity. Every step is optimized to simplify analysis and reporting to support our microplate readers.
-
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Explore a line of validation products and services addressing different levels of validation needs based on individual risk assessment. They're designed to allow “continuous validation” for FDA-regulated companies.